iMeds.se

Reminyl

Information för alternativet: Reminyl 12 Mg Filmdragerad Tablett, Reminyl 4 Mg Filmdragerad Tablett, Reminyl 8 Mg Filmdragerad Tablett, visar 4 alternativ
Document: Reminyl film-coated tablet ENG PL change

Package leaflet: Information for the user


Reminyl 4 mg film‑coated tablets

Reminyl 8 mg film‑coated tablets

Reminyl 12 mg film‑coated tablets


galantamine


Read all of this leaflet carefully before you start taking this medicine because if contains important information for you.

- Keep this leaflet. You may need to read it again.

- If you have any further questions, ask your doctor or pharmacist.

- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.


What is in this leaflet

What Reminyl is and what it is used for

What you need to know before you take Reminyl

How to take Reminyl

Possible side effects

How to store Reminyl

Contents of the pack and other information.


1. What Reminyl is and what it is used for


Reminyl contains the active substance ‘galantamine’, an antidementia medicine. It is used in adults to treat the symptoms of mild to moderately severe Alzheimer’s disease, a type of dementia that alters brain function.


Alzheimer’s disease causes increasing memory loss, confusion and behavioural changes, which make it increasingly difficult to carry out normal daily activities. These effects are thought to be caused by a lack of ‘acetylcholine’, a substance responsible for sending messages between brain cells. Reminyl increases the amount of acetylcholine in the brain and treats the signs of the disease.


2. What you need to know before you take Reminyl


Do not take Reminyl


Warnings and precautions

Talk to your doctor or pharmacist before taking Reminyl. This medicine is only used in Alzheimer’s disease, and is not recommended for other types of memory loss or confusion.


Serious side effects

Reminyl can cause serious skin reactions, heart problems and fits (seizures). You must be aware of these side effects while you are taking Reminyl. See ‘Look out for serious side effects’ in section 4.


Before you take Reminyl, your doctor needs to know if you have, or have had, any of the following:

Your doctor will decide if Reminyl is suitable for you, or if the dose needs to be changed.


Also tell your doctor if you recently had an operation on the stomach, intestines or bladder. Your doctor may decide that Reminyl is not suitable for you.


Reminyl can cause weight loss. Your doctor will check your weight regularly while you are taking Reminyl.


Children and adolescents

Reminyl is not recommended for children and adolescents.


Other medicines and Reminyl

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.


Reminyl should not be used with medicines that work in a similar way. These include:


Some medicines can make side effects more likely in people taking Reminyl. These include:

Your doctor may give you a lower dose of Reminyl if you are taking some of these medicines.


Reminyl may affect some anaesthetics. If you are going to have an operation under a general anaesthetic, tell the doctor that you are taking Reminyl, well in advance.


If you have any questions, talk to your doctor or pharmacist for advice.


Pregnancy and breast-feeding

If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.


You should not breast‑feed while you are taking Reminyl.


Driving and using machines

Reminyl may make you feel dizzy or sleepy, especially during the first few weeks of treatment. If Reminyl affects you, do not drive or use any tools or machinery.


Reminyl tablets contain lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.


Reminyl 12 mg (orange‑brown) tablets contain orange-yellow S aluminium lake

The colouring in these tablets may cause allergic reactions.


3. How to take Reminyl tablets


Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.


How much to take

You will start treatment with Reminyl at a low dose. The usual starting dose is 4 mg, taken twice a day (a total of 8 mg a day). Your doctor may gradually increase your dose, every 4 weeks or more, until you reach a dose that is suitable for you. The maximum dose is 12 mg, taken twice a day (a total of 24 mg a day).


Your doctor will explain what dose to start with and when the dose should be increased. If you are not sure what to do, or find the effect of Reminyl is too strong or too weak, talk to your doctor or pharmacist.


Your doctor will need to see you regularly, to check that this medicine is working and to discuss how you are feeling.


If you have liver or kidney problems, your doctor may give you a reduced dose of Reminyl, or may decide this medicine is not suitable for you.


How to take

Take your dose of Reminyl twice a day, in the morning and evening, with water or other liquids. Try to take Reminyl with food.


Drink plenty of liquids while you are taking Reminyl, to keep yourself hydrated.


If you take more Reminyl than you should

If you take too much Reminyl, contact a doctor or hospital straight away. Take any remaining tablets and the packaging with you. The signs of overdose may include:

severe nausea and vomiting

weak muscles, slow heart beat, fits (seizures) and loss of consciousness.


If you forget to take Reminyl

If you forget to take one dose, miss out the forgotten dose completely and take the next dose at the normal time. Do not take a double dose to make up for a forgotten dose.


If you forget to take more than one dose, contact your doctor.


If you stop taking Reminyl

Check with your doctor before you stop taking Reminyl. It is important to continue taking this medicine to treat your condition.


If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


4. Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.


Look out for serious side effects


Stop taking Reminyl and see a doctor or go to your nearest emergency department immediately if you notice any of the following.


Skin reactions, including:

These skin reactions are rare in people taking Reminyl (may affect up to 1 in 1,000 people).


Heart problems, including changes in heart beat (such as a slow beat, extra beats) or palpitations (heart beat feels fast or uneven). Heart problems may show as an abnormal tracing on an ‘electrocardiogram’ (ECG), and can be common in people taking Reminyl (may affect up to 1 in 10 people).


Fits (seizures). These are uncommon in people taking Reminyl (may affect up to 1 in 100 people).


You must stop taking Reminyl and get help immediately if you notice any of the side effects above.


Other side effects


Very common side effects (may affect more than 1 in 10 people):

Nausea and vomiting. These side effects are more likely to happen in the first few weeks of treatment or when the dose is increased. They tend to disappear gradually as the body gets used to the medicine and generally only last for a few days. If you have these effects, your doctor may recommend that you drink more liquids, and may prescribe a medicine to stop you being sick.


Common side effects (may affect up to 1 in 10 people):


Uncommon side effects (may affect up to 1 in 100 people):


Rare side effects (may affect up to 1 in 1,000 people):

Inflamed liver (hepatitis).

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.


5. How to store Reminyl


Keep this medicine out of the sight and reach of children.


Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.


This medicine does not require any special storage conditions.


Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


6. Contents of the pack and other information


What Reminyl contains

Colloidal anhydrous silica, crospovidone, lactose monohydrate, magnesium stearate, microcrystalline cellulose, hypromellose, propylene glycol, talc and titanium dioxide (E171).
The 4 mg tablets also contain yellow ferric oxide (E172).

The 8 mg tablets also contain red ferric oxide (E172).

The 12 mg tablets also contain red ferric oxide (E172) and orange-yellow S aluminium lake (E110).


What Reminyl looks like and contents of the pack

Reminyl 4 mg tablets are off-white, round and marked ‘G4’ on one side and ‘JANSSEN’ on the other side. Each pack contains blisters of 14 or 56 tablets.

Reminyl 8 mg tablets are pink, round and marked ‘G8’ on one side and ‘JANSSEN’ on the other side. Each pack contains blisters of 14, 56 or 112 tablets.

Reminyl 12 mg tablets are orange-brown, round and marked ‘G12’ on one side and ‘JANSSEN’ on the other side. Each pack contains blisters of 56, 112 or 168 tablets.


Not all pack sizes may be marketed.


Marketing Authorisation Holder

[To be completed nationally]


Manufacturer

Janssen-Cilag SpA, Via C. Janssen, 04100 Borgo San Michele, Latina, Italy.

McGregor Cory Ltd., Exel, Site 1 Middleton Close, Banbury, Oxfordshire, OX16 4RS, UK.


This medicinal product is authorised in the Member States of the EEA under the following names:


Austria Reminyl 4 mg, 8 mg, 12 mg - Filmtabletten

Belgium Reminyl 4 mg, 8 mg, 12 mg filmomhulde tabletten

Denmark Reminyl 4 mg, 8 mg, 12 mg filmovertrukne tabletter

Finland Reminyl 4 mg, 8 mg, 12 mg kalvopäällysteiset tabletit

France Reminyl 4 mg, 8 mg, 12 mg comprimé pelliculé

Greece Reminyl 4 mg, 8 mg, 12 mg επικαλυμμένα με λεπτό υμένιο δισκία

Iceland Reminyl 4 mg, 8 mg, 12 mg filmúhuðaðar töflur

Ireland Reminyl 4 mg, 8 mg, 12 mg tablets

Italy Reminyl 4 mg, 8 mg, 12 mg compresse rivestite con film

Luxembourg Reminyl 4 mg, 8 mg, 12 mg comprimé pelliculé

Netherlands Reminyl 4 mg, 8 mg, 12 mg, filmomhulde tabletten

Norway Reminyl 4 mg, 8 mg, 12 mg filmdrasjerte tabletter

Portugal Reminyl 4 mg, 8 mg, 12 mg comprimidos revestidos

Spain Reminyl 4 mg, 8 mg, 12 mg comprimidos recubiertos

Sweden Reminyl 4 mg, 8 mg, 12 mg filmdragerade tabletter

UK Reminyl 4 mg, 8 mg, 12 mg tablets


This leaflet was last revised in 2015-08-21


12